Non-Coding RNAs As Mediators of Epigenetic Changes in Malignancies

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2020 Dec 9

PMID 33291485

Citations 40

Authors

Subhasree Kumar

Edward A Gonzalez

Pranela Rameshwar

Jean-Pierre Etchegaray

Affiliations

Soon will be listed here.

Abstract

Non-coding RNAs (ncRNAs) are untranslated RNA molecules that regulate gene expressions. NcRNAs include small nuclear RNAs (snRNAs), small nucleolar RNAs (snoRNAs), ribosomal RNAs (rRNAs), transfer RNAs (tRNAs), circular RNAs (cRNAs) and piwi-interacting RNAs (piRNAs). This review focuses on two types of ncRNAs: microRNAs (miRNAs) or short interfering RNAs (siRNAs) and long non-coding RNAs (lncRNAs). We highlight the mechanisms by which miRNAs and lncRNAs impact the epigenome in the context of cancer. Both miRNAs and lncRNAs have the ability to interact with numerous epigenetic modifiers and transcription factors to influence gene expression. The aberrant expression of these ncRNAs is associated with the development and progression of tumors. The primary reason for their deregulated expression can be attributed to epigenetic alterations. Epigenetic alterations can cause the misregulation of ncRNAs. The experimental evidence indicated that most abnormally expressed ncRNAs impact cellular proliferation and apoptotic pathways, and such changes are cancer-dependent. In vitro and in vivo experiments show that, depending on the cancer type, either the upregulation or downregulation of ncRNAs can prevent the proliferation and progression of cancer. Therefore, a better understanding on how ncRNAs impact tumorigenesis could serve to develop new therapeutic treatments. Here, we review the involvement of ncRNAs in cancer epigenetics and highlight their use in clinical therapy.

Citing Articles

Epigenetic and epitranscriptomic role of lncRNA in carcinogenesis (Review).

Dai C, Qianjiang H, Fu R, Yang H, Shi A, Luo H Int J Oncol. 2025; 66(4).

PMID: 40017127 PMC: 11900940. DOI: 10.3892/ijo.2025.5735.

Epigenomic Echoes-Decoding Genomic and Epigenetic Instability to Distinguish Lung Cancer Types and Predict Relapse.

Baumann A, Buribayev Z, Wolkenhauer O, Salybekov A, Wolfien M Epigenomes. 2025; 9(1).

PMID: 39982247 PMC: 11843950. DOI: 10.3390/epigenomes9010005.

The role of lncRNAs in the interplay of signaling pathways and epigenetic mechanisms in glioma.

Bora Yildiz C, Du J, Mohan K, Zimmer-Bensch G, Abdolahi S Epigenomics. 2025; 17(2):125-140.

PMID: 39829063 PMC: 11792803. DOI: 10.1080/17501911.2024.2442297.

Crosstalk between non-coding RNAs and programmed cell death in colorectal cancer: implications for targeted therapy.

Taha S, Karimi M, Mahdavi B, Yousefi Tehrani M, Bemani A, Kabirian S Epigenetics Chromatin. 2025; 18(1):3.

PMID: 39810224 PMC: 11734566. DOI: 10.1186/s13072-024-00560-8.

Inhibiting lncRNA NEAT1 Increases Glioblastoma Response to TMZ by Reducing Connexin 43 Expression.

Liang J, Xie J, He J, Li Y, Wei D, Zhou R Cancer Rep (Hoboken). 2024; 7(10):e70031.

PMID: 39453684 PMC: 11505515. DOI: 10.1002/cnr2.70031.

References

Noonan E, Place R, Pookot D, Basak S, Whitson J, Hirata H . miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene. 2009; 28(14):1714-24. DOI: 10.1038/onc.2009.19. View

Nguyen T, Rich A, Dahl R . MiR-24 promotes the survival of hematopoietic cells. PLoS One. 2013; 8(1):e55406. PMC: 3559586. DOI: 10.1371/journal.pone.0055406. View

Jurica M, Moore M . Pre-mRNA splicing: awash in a sea of proteins. Mol Cell. 2003; 12(1):5-14. DOI: 10.1016/s1097-2765(03)00270-3. View

Miyagishi M, Taira K . U6 promoter-driven siRNAs with four uridine 3' overhangs efficiently suppress targeted gene expression in mammalian cells. Nat Biotechnol. 2002; 20(5):497-500. DOI: 10.1038/nbt0502-497. View

Kim Y, Maizel A, Chen X . Traffic into silence: endomembranes and post-transcriptional RNA silencing. EMBO J. 2014; 33(9):968-80. PMC: 4193931. DOI: 10.1002/embj.201387262. View

Shaham L, Binder V, Gefen N, Borkhardt A, Izraeli S . MiR-125 in normal and malignant hematopoiesis. Leukemia. 2012; 26(9):2011-8. DOI: 10.1038/leu.2012.90. View

Liu J, Zhang S, Cheng B . Epigenetic roles of PIWI‑interacting RNAs (piRNAs) in cancer metastasis (Review). Oncol Rep. 2018; 40(5):2423-2434. DOI: 10.3892/or.2018.6684. View

Moussay E, Wang K, Cho J, Van Moer K, Pierson S, Paggetti J . MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2011; 108(16):6573-8. PMC: 3081030. DOI: 10.1073/pnas.1019557108. View

Chen C, Blanco M, Jackson C, Aznauryan E, Ollikainen N, Surka C . Xist recruits the X chromosome to the nuclear lamina to enable chromosome-wide silencing. Science. 2016; 354(6311):468-472. DOI: 10.1126/science.aae0047. View

10.

Wang K, Chang H . Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011; 43(6):904-14. PMC: 3199020. DOI: 10.1016/j.molcel.2011.08.018. View

11.

Cimmino A, Calin G, Fabbri M, Iorio M, Ferracin M, Shimizu M . miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005; 102(39):13944-9. PMC: 1236577. DOI: 10.1073/pnas.0506654102. View

12.

Sun M, Gadad S, Kim D, Kraus W . Discovery, Annotation, and Functional Analysis of Long Noncoding RNAs Controlling Cell-Cycle Gene Expression and Proliferation in Breast Cancer Cells. Mol Cell. 2015; 59(4):698-711. PMC: 4546522. DOI: 10.1016/j.molcel.2015.06.023. View

13.

Xing C, Hu X, Xie F, Yu Z, Li H, Bin-Zhou . Long non-coding RNA HOTAIR modulates c-KIT expression through sponging miR-193a in acute myeloid leukemia. FEBS Lett. 2015; 589(15):1981-7. DOI: 10.1016/j.febslet.2015.04.061. View

14.

Wang H, Huo X, Yang X, He J, Cheng L, Wang N . STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4. Mol Cancer. 2017; 16(1):136. PMC: 5558651. DOI: 10.1186/s12943-017-0680-1. View

15.

Benetatos L, Hatzimichael E, Dasoula A, Dranitsaris G, Tsiara S, Syrrou M . CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes. Leuk Res. 2009; 34(2):148-53. DOI: 10.1016/j.leukres.2009.06.019. View

16.

He F, Song Z, Chen H, Chen Z, Yang P, Li W . Long noncoding RNA PVT1-214 promotes proliferation and invasion of colorectal cancer by stabilizing Lin28 and interacting with miR-128. Oncogene. 2018; 38(2):164-179. PMC: 6329639. DOI: 10.1038/s41388-018-0432-8. View

17.

Yang L, Bai H, Deng Y, Fan L . High MALAT1 expression predicts a poor prognosis of cervical cancer and promotes cancer cell growth and invasion. Eur Rev Med Pharmacol Sci. 2015; 19(17):3187-93. View

18.

Matera A, Terns R, Terns M . Non-coding RNAs: lessons from the small nuclear and small nucleolar RNAs. Nat Rev Mol Cell Biol. 2007; 8(3):209-20. DOI: 10.1038/nrm2124. View

19.

Chi J, Li J, Jia J, Zhang T, Liu X, Yi L . Long non-coding RNA ANRIL in gene regulation and its duality in atherosclerosis. J Huazhong Univ Sci Technolog Med Sci. 2017; 37(6):816-822. DOI: 10.1007/s11596-017-1812-y. View

20.

Eis P, Tam W, Sun L, Chadburn A, Li Z, Gomez M . Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A. 2005; 102(10):3627-32. PMC: 552785. DOI: 10.1073/pnas.0500613102. View